These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1997159

  • 1. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
    Del Bino G, Darzynkiewicz Z.
    Cancer Res; 1991 Feb 15; 51(4):1165-9. PubMed ID: 1997159
    [Abstract] [Full Text] [Related]

  • 2. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
    Hotz MA, Del Bino G, Lassota P, Traganos F, Darzynkiewicz Z.
    Cancer Res; 1992 Mar 15; 52(6):1530-5. PubMed ID: 1540962
    [Abstract] [Full Text] [Related]

  • 3. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide.
    Gorczyca W, Bruno S, Melamed MR, Darzynkiewicz Z.
    Cancer Res; 1992 Jun 15; 52(12):3491-4. PubMed ID: 1596908
    [Abstract] [Full Text] [Related]

  • 4. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
    Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z.
    Cancer Res; 1992 Nov 15; 52(22):6200-8. PubMed ID: 1330289
    [Abstract] [Full Text] [Related]

  • 5. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 6. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
    Del Bino G, Skierski JS, Darzynkiewicz Z.
    Cancer Res; 1990 Sep 15; 50(18):5746-50. PubMed ID: 2168279
    [Abstract] [Full Text] [Related]

  • 7. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G, Skierski JS, Darzynkiewicz Z.
    Exp Cell Res; 1991 Aug 15; 195(2):485-91. PubMed ID: 1649059
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.
    Del Bino G, Bruno S, Yi PN, Darzynkiewicz Z.
    Cell Prolif; 1992 Nov 15; 25(6):537-48. PubMed ID: 1333822
    [Abstract] [Full Text] [Related]

  • 10. A novel use for the comet assay: detection of topoisomerase II inhibitors.
    Salti GI, Das Gupta TK, Constantinou AI.
    Anticancer Res; 2000 Nov 15; 20(5A):3189-93. PubMed ID: 11062742
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases.
    Bruno S, Lassota P, Giaretti W, Darzynkiewicz Z.
    Oncol Res; 1992 Nov 15; 4(1):29-35. PubMed ID: 1374671
    [Abstract] [Full Text] [Related]

  • 12. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26.
    Chen M, Beck WT.
    Cancer Res; 1995 Apr 01; 55(7):1509-16. PubMed ID: 7882360
    [Abstract] [Full Text] [Related]

  • 13. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays.
    Gorczyca W, Gong J, Darzynkiewicz Z.
    Cancer Res; 1993 Apr 15; 53(8):1945-51. PubMed ID: 8467513
    [Abstract] [Full Text] [Related]

  • 14. DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors.
    Wolverton JS, Danks MK, Granzen B, Beck WT.
    Cancer Res; 1992 Aug 01; 52(15):4248-53. PubMed ID: 1322239
    [Abstract] [Full Text] [Related]

  • 15. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
    Lin JH, Castora FJ.
    Arch Biochem Biophys; 1995 Dec 20; 324(2):293-9. PubMed ID: 8554321
    [Abstract] [Full Text] [Related]

  • 16. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
    Borgnetto ME, Zunino F, Tinelli S, Kas E, Capranico G.
    Cancer Res; 1996 Apr 15; 56(8):1855-62. PubMed ID: 8620504
    [Abstract] [Full Text] [Related]

  • 17. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
    Traganos F, Kapuscinski J, Gong J, Ardelt B, Darzynkiewicz RJ, Darzynkiewicz Z.
    Cancer Res; 1993 Oct 01; 53(19):4613-8. PubMed ID: 8402636
    [Abstract] [Full Text] [Related]

  • 18. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z.
    Cancer Res; 1993 Jul 01; 53(13):3186-92. PubMed ID: 8319228
    [Abstract] [Full Text] [Related]

  • 19. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC, Ashorn CL, Chan D, Zwelling LA.
    Cancer Res; 1989 Apr 15; 49(8):2052-8. PubMed ID: 2539251
    [Abstract] [Full Text] [Related]

  • 20. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin.
    Gong J, Li X, Darzynkiewicz Z.
    J Cell Physiol; 1993 Nov 15; 157(2):263-70. PubMed ID: 8227159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.